NAYA NAYA Biosciences Inc: Sof foyda bo'yicha sotuv rentabelligi

NAYA Biosciences (NAYA) grafik logotipi

NAYA Biosciences (NAYA) kompaniyasining gen modifikatsiyasi va reproduktiv tibbiyotdagi istiqbollari joriy tendentsiyani harakatga keltirmoqda, shu bilan birga kompaniyaning savdo marjalari yangi -122.80 parametrini namoyish etmoqda. O'sish FLEX-NK platformasining yopiq patentlariga asoslangan, garchi bozor hozirda aktivlarni spekulyativ tarzda baholab, rahbariyatning muvaffaqiyatini kutayotgan bo'lsa-da. Daromadlilik tahlili shov-shuvli davrlarda aksiya uchun haddan tashqari ko'p to'lov qilishning oldini olishga yordam beradi.

NAYA Biosciences Corp (NAYA) - Sof marja 04.07.2022dan 28.04.2025gacha

NAYA Biosciences kompaniyasining tahliliy kesimlari

- aksiya kursi va ekspertlarning narx prognozi:
Kompaniyaning barcha koʻrsatkichlari tahlili:NAYA Biosciences Inc - NAYA
NAYA Bio ishlab chiqargan mahsulot

Daromadning foydaga aylanish samaradorligini tahlil qilish sektorning fundamental yetakchilarini tanlash uchun juda muhimdir. Ushbu ko'rsatkich barcha operatsion xarajatlar chegirib tashlanganidan keyingi sof foydaning umumiy savdo hajmidagi ulushini o'lchaydi. Antitelalarni ishlab chiqishda tashqi investitsiyalarga tayanadigan NAYA Biosciences (NAYA) uchun ushbu hisob-kitob kapital inyeksiyalariga bo'lgan bog'liqlik darajasini ochib beradi. Sof foyda marjasi tarixini tahlil qilish orqali investor barqaror tijorat mahsulotlari yo'qligida biznesning yashirin emirilishini aniqlashi mumkin.

Asosiy raqobatchilar

ONC: Sotuvning sof marjinal rentabelligi|Sof marja Halozyme Inc. (HALO)|Sof marja RevMed|Sotuvning sof rentabelligi AAPG (Ascentage Pharma Group)|Sotuvning sof marjinal rentabelligi CGON|UroGen Pharma - Sotuvning sof rentabelligi|Bicara Therapeutics - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof marjinal rentabelligi Personalis Inc PSNL|Erasca Oncology - Sotuvning sof marjinal rentabelligi|Sof foyda normasi DCTH (Delcath Corp)|YMAB: Sotuvning sof marjinal rentabelligi|AURA - Kompaniya sotuv marjasi|CADL (Candel Therapeutics Inc.) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi ARAY (Accuray)|Sof foyda bo'yicha sotuv rentabelligi SLS (SELLAS Life Sciences Group, Inc.)|ACTU - Sof marja|Sof marja Citius Oncology, Inc. CTOR|HURA - Sof foyda bo'yicha sotuv rentabelligi|protaratx.com - Sotuvning sof marjinal rentabelligi|FATE - Sotuvning sof marjinal rentabelligi|WHWK: Sotuvning sof marjinal rentabelligi|TScan Therapeutics (TCRX) - Sotuvning sof marjinal rentabelligi|Sof marja Champions Oncology|Sof marja XBIT|Sotuvning sof marjinal rentabelligi CVM|Sof foyda bo'yicha sotuv rentabelligi OS Therapies Inc. OSTX|Sof marja Radiopharm Theranostics Limited RADX|artivabio.com (ARTV) - Sof marja|ANL - Sof marja|Sof marja verupharma.com|TPST: Sotuvning sof marjinal rentabelligi|XLO - Kompaniya sotuv marjasi|Sof marja Renovaro|Sotuvning sof marjinal rentabelligi muraloncology.com|Sotuvning sof marjinal rentabelligi KAPA|Kompaniya sotuv marjasi OnKure Therapeutics, Inc.|Sotuvning sof marjinal rentabelligi GDTC (w2.cytomed.sg)|CRIS - Sof foyda bo'yicha sotuv rentabelligi|Apollomics - Sotuvning sof marjinal rentabelligi|Tharimmune Corp (THAR) - Sof foyda bo'yicha sotuv rentabelligi|ADVB: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi Genprex|CLDI (Calidi Biotherapeutics, Inc.) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi SBFM (Sunshine Biopharma)|Sof marja Xenetic Bio (XBIO)|Sof marja SLRX (Salarius Pharma)|Kitov Pharma - Sof foyda bo'yicha sotuv rentabelligi|American Oncology Network (AONC) - Sof marja|BeiGene - Sotuvning sof marjinal rentabelligi|Checkpoint Therapeutics, Inc. (CKPT) - Sof foyda bo'yicha sotuv rentabelligi|ELEV (Elevation Oncology, Inc.) - Sof foyda bo'yicha sotuv rentabelligi|iCAD Inc. - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi IKNA|Sotuvning sof marjinal rentabelligi notablelabs.com|Sof foyda bo'yicha sotuv rentabelligi VIRX (Viracta Therapeutics Inc.)|MOR - Sof marja|Sotuvning sof marjinal rentabelligi AAPGV (Ascentage)